Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02647918
What this trial is testing

Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function

Who this might be right for
Renal ImpairmentHealthy
Lexicon Pharmaceuticals 50
Testing effectiveness (Phase 2)Looking for participantsNCT07661940
What this trial is testing

Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine

Who this might be right for
AKI - Acute Kidney Injury
University of Erlangen-Nürnberg Medical School 120
Early research (Phase 1)Study completedNCT03443063
What this trial is testing

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment

Who this might be right for
Renal Impairment
Eisai Inc. 16
Large-scale testing (Phase 3)Study completedNCT02652819
What this trial is testing

FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis

Who this might be right for
Anemia
Kyntra Bio 154
Early research (Phase 1)Study completedNCT01452828
What this trial is testing

A Pharmacokinetics and Safety Study in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Early research (Phase 1)Study completedNCT05711381
What this trial is testing

Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function

Who this might be right for
Renal Impairment
Hanmi Pharmaceutical Company Limited 16
Testing effectiveness (Phase 2)Study completedNCT02064426
What this trial is testing

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 88
Large-scale testing (Phase 3)Study completedNCT03409107
What this trial is testing

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Who this might be right for
Anaemia
GlaxoSmithKline 614
Testing effectiveness (Phase 2)Study completedNCT00752609
What this trial is testing

Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

Who this might be right for
Anemia
Takeda 102
Early research (Phase 1)WithdrawnNCT03545087
What this trial is testing

Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants

Who this might be right for
Renal Insufficiency
Eli Lilly and Company
Early research (Phase 1)Study completedNCT03259087
What this trial is testing

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT01462136
What this trial is testing

PK Study of ACHN-490 Injection in Renally Impaired Subjects

Who this might be right for
Renal Insufficiency
Achaogen, Inc. 24
Early research (Phase 1)Study completedNCT01571999
What this trial is testing

Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 17
Early research (Phase 1)Study completedNCT02084199
What this trial is testing

Study to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Renal Impairment
Lakefront Biotherapeutics NV 24
Early research (Phase 1)Study completedNCT03961932
What this trial is testing

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Participants
ObsEva SA 33
Early research (Phase 1)Study completedNCT03844555
What this trial is testing

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

Who this might be right for
Renal ImpairmentRenal InsufficiencyKidney Diseases+1 more
Genfit 23
Post-approval studies (Phase 4)Study completedNCT03256838
What this trial is testing

Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

Who this might be right for
Kidney Failure, ChronicEnd-stage Renal DiseasePhosphorus Metabolism Disorders+1 more
Panion & BF Biotech Inc. 202
Testing effectiveness (Phase 2)Study completedNCT05834738
What this trial is testing

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 54
Early research (Phase 1)Study completedNCT01791855
What this trial is testing

PF-04634817 Renal Impairment Study

Who this might be right for
Renal Insufficiency
Pfizer 32
Early research (Phase 1)Study completedNCT01331941
What this trial is testing

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

Who this might be right for
Advanced Solid TumorsKidney DiseaseRenal Impairment
Amgen 35
Next Page